Close Menu

    Subscribe to Updates

    Get the latest creative news from Healthradar about News,Health and Gadgets.

    Bitte aktiviere JavaScript in deinem Browser, um dieses Formular fertigzustellen.
    Wird geladen
    What's Hot

    As well as the Galaxy Ring 2, Samsung is also looking at smart earrings, necklaces, and other wearables

    13. Juli 2025

    Charges dropped against Utah doctor accused of throwing away $28,000 in COVID vaccine doses

    13. Juli 2025

    ‘Tremendous uncertainty’ for cancer research as US officials target mRNA vaccines | Amid Trump cuts and state-level backlash, experts worry that progress in messenger RNA vaccines could stall

    13. Juli 2025
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram Pinterest Vimeo
    healthradar.nethealthradar.net
    • Home
    • Ai
    • Gadgets
    • Health
    • News
    • Contact Us
    Contact
    healthradar.nethealthradar.net
    Home»News»Abbott gains national CMS coverage for tricuspid valve repair
    News

    Abbott gains national CMS coverage for tricuspid valve repair

    HealthradarBy Healthradar10. Juli 2025Keine Kommentare2 Mins Read
    Share Facebook Twitter Pinterest LinkedIn Tumblr Reddit Telegram Email
    Abbott gains national CMS coverage for tricuspid valve repair
    Share
    Facebook Twitter LinkedIn Pinterest Email


    This audio is auto-generated. Please let us know if you have feedback.

    The Centers for Medicare and Medicaid Services has agreed to cover transcatheter edge-to-edge repair for tricuspid valve regurgitation, including Abbott’s TriClip system.

    In a LinkedIn post, Abbott called the national coverage determination a milestone for patients with severe tricuspid regurgitation that will support broader access to a minimally invasive treatment for those who are not good candidates for surgery.

    “This decision helps open the door to treatment for more people living with symptomatic severe tricuspid regurgitation – many of whom have had few options in the past. It also provides additional clarity for care teams working to bring minimally invasive solutions to these complex patients,” Sandra Lesenfants, senior vice president of Abbott’s structural heart division, said on LinkedIn.

    Abbott’s device is now included in the Medicare NCD, according to the post.

    Abbott requested a national coverage analysis for the tricuspid valve repair procedure, also known as T-TEER, in March 2023, as the Food and Drug Administration conducted a parallel review of its TriClip device. TriClip received FDA approval in April 2024.

    Tricuspid regurgitation is a condition where the valve between the two right heart chambers doesn’t close properly, allowing blood to leak backward. It can reduce the amount of blood pumped through the body, causing the heart to work harder, and can lead to shortness of breath, atrial fibrillation and heart failure if untreated.

    Abbott’s TriClip device pulls together the leaflets of the tricuspid valve with a clip to help blood flow in the right direction and reduce leaking.

    In data presented at the American College of Cardiology meeting earlier this year, patients with severe tricuspid regurgitation who received a TriClip device with medical therapy were 28% less likely to be hospitalized for recurrent heart failure at two years than those treated with drugs alone.

    Abbott competitor Edwards Lifesciences makes a transcatheter tricuspid valve replacement device called Evoque to treat tricuspid regurgitation. Evoque won FDA approval in February 2024.



    Source link

    Abbott CMS coverage Gains National repair tricuspid valve
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Previous ArticleGarmin just gave some of its smartwatches a big Google Maps upgrade – here’s which models are getting it
    Next Article Neuros raises $56M to commercialize nerve stimulation system for post-amputation pain
    ekass777x
    Healthradar
    • Website

    Related Posts

    News

    Zyter|TruCare Appoints Sundar Subramanian as CEO

    12. Juli 2025
    News

    Ryght Partners w/ Emory Cancer Institute for AI-powered Clinical Trials

    12. Juli 2025
    News

    Top U.S. Health Systems Partner with Clasp to Combat Student Debt and Clinical Staffing Shortages

    12. Juli 2025
    Add A Comment
    Leave A Reply Cancel Reply

    Top Posts

    New surgeon general nominee cofounded a16z backed health app with DOGE operative

    1. Juni 20257 Views

    Neurode wants to treat and track ADHD symptoms through a wearable headband

    1. Juni 20255 Views

    Whoop wants everyone to give a whoop about the new Whoop 5.0

    1. Juni 20254 Views

    Baby Boomers’ Luck Is Running Out

    14. Juni 20253 Views
    Stay In Touch
    • Facebook
    • YouTube
    • TikTok
    • WhatsApp
    • Twitter
    • Instagram
    Latest Reviews

    Subscribe to Updates

    Bitte aktiviere JavaScript in deinem Browser, um dieses Formular fertigzustellen.
    Wird geladen
    About Us

    Welcome to HealthRadar.net — your trusted destination for discovering the latest innovations in digital health. We are dedicated to connecting individuals, healthcare professionals, and organizations with cutting-edge tools, applications

    Most Popular

    New surgeon general nominee cofounded a16z backed health app with DOGE operative

    1. Juni 20257 Views

    Neurode wants to treat and track ADHD symptoms through a wearable headband

    1. Juni 20255 Views
    USEFULL LINK
    • About Us
    • Contact Us
    • Disclaimer
    • Privacy Policy
    QUICK LINKS
    • Ai
    • Gadgets
    • Health
    • News
    • About Us
    • Contact Us
    • Disclaimer
    • Privacy Policy
    Copyright© 2025 Healthradar All Rights Reserved.

    Type above and press Enter to search. Press Esc to cancel.